The Journal of Pain
Volume 11, Issue 1 , Pages 71-78 , January 2010

Interaction of Morphine With a New α2-Adrenoceptor Agonist in Mice

  • Roberto T. Sudo

      Affiliations

    • Programa de Desenvolvimento de Fármacos, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil
    • Corresponding Author InformationAddress reprint requests to Dr. Roberto T. Sudo, Programa de Desenvolvimento de Fármacos, Instituto de Ciências Biomédicas, Centro de Ciências da Saúde, Bloco J, Sala 14, Rio de Janeiro, Brazil, CEP 21941-590.
    • ,
  • Jorge A. Calasans-Maia

      Affiliations

    • Serviço de Anestesiologia e Programa de Pós-Gradução em Medicina (Cirurgia), Universidade Federal do Rio de Janeiro, Brazil
    • ,
  • Suely L. Galdino

      Affiliations

    • Núcleo de Pesquisa em Inovação Terapêutica, Universidade Federal de Pernambuco, Brazil
    • ,
  • Maria C.A. Lima

      Affiliations

    • Núcleo de Pesquisa em Inovação Terapêutica, Universidade Federal de Pernambuco, Brazil
    • ,
  • Gisele Zapata-Sudo

      Affiliations

    • Programa de Desenvolvimento de Fármacos, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil
    • ,
  • Marcelo Z. Hernandes

      Affiliations

    • Núcleo de Pesquisa em Inovação Terapêutica, Universidade Federal de Pernambuco, Brazil
    • ,
  • Ivan R. Pitta

      Affiliations

    • Núcleo de Pesquisa em Inovação Terapêutica, Universidade Federal de Pernambuco, Brazil

Received 9 March 2009 ,Revised 8 July 2009 ,Accepted 4 August 2009.

References 

  1. Ansah OB, Pertovaara A. Peripheral suppression of arthritic pain by intraarticular fadolmidine, an alpha 2-adrenoceptor agonist, in the rat. Anesth Analg. 2007;105:245–250
  2. Bexis S, Docherty J. Role of α2A-adrenoceptors in the effects of MDMA on body temperature in the mouse. Br J Pharmacol. 2005;146:1–6
  3. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000;59:263–268
  4. Brandão SSF, Andrade AMC, Pereira DTM, Barbosa Filho JM, Lima MCA, Galdino SL, et al. 1,3,5-Trisubstituted-2-thioxoimidazolidinones: A novel way of synthesis. Heterocyclic Communications. 2004;10:9–14
  5. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, et al. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev. 1994;46:121–136
  6. Calasans-Maia JA, Zapata-Sudo G, Sudo RT. Dexmedetomidine prolongs spinal anaesthesia induced by levobupivacaine 0.5% in guinea-pigs. J Pharm Pharmacol. 2005;57:1415–1420
  7. Deutsch E, Tobias JD. Hemodynamic and respiratory changes following dexmedetomidine administration during general anesthesia: sevoflurane vs desflurane. Paediatr Anaesth. 2007;17:438–444
  8. Dewar MJS, Zoebisch EG, Healy EF, Stewart JJP. Development and use of quantum mechanical molecular models. 76. AM1: A new general purpose quantum mechanical molecular model. J Am Chem Soc. 1985;107:3902–3909
  9. Dogrul A, Coskun I, Uzbay T. The contribution of alpha-1 and alpha-2 adrenoceptors in peripheral imidazoline and adrenoceptor agonist-induced nociception. Anesth Analg. 2006;103:471–477
  10. Drasner K, Fields HL. Synergy between the antinociceptive effects of intrathecal clonidine and systemic morphine in the rat. Pain. 1988;32:309–312
  11. Fairbanks CA, Stone LS, Kitto KF, Nguyen O, Posthumus IJ, Wilcox GL. α2C-adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther. 2002;300:282–290
  12. Galeotti N, Bartolini A, Ghelardini C. Alpha 2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. Behav Brain Res. 2004;153:409–417
  13. Hunter JC, Fontana DJ, Hedley RL, Jasper JR, Lewis R, Link RE, et al. Assessment of the role of alpha2-adrenoceptors subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol. 1997;122:1339–1344
  14. Jain AN. Surflex: Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search Engine. J Med Chem. 2003;46:499–511
  15. Kamibayashi T, Maze M. Clinical uses of α2-adrenergic agonists. Anesthesiology. 2000;93:1345–1349
  16. Kanazi GE, Aouad MT, Jabbour-Khoury SI, Al Jazzar MD, Alameddine MM, Al-Yaman R, et al. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand. 2006;50:222–227
  17. Lakhani PP, Macmillan LB, Guo TZ, Mccool BA, Lovinger DM, Maze M, et al. Substitution of a mutant alpha(2a)-adrenergic receptor via hit and run gene targeting reveals the role of this subtype in sedative, analgesic and anesthetic-sparing responses in vivo. Proc Natl Acad Sci USA. 1997;94:9950–9955
  18. Laudenbach V, Mantz J, Lagercrantz H, Desmonts JM, Evrard P, Gressens P. Effects of α2-adrenoceptor agonists on perinatal excitotoxic brain injury: Comparison of clonidine and dexmedetomidine. Anesthesiology. 2002;96:134–141
  19. Laurila JMM, Xhaard H, Ruuskanen JO, Rantanen MJM, Karlsson HK, Johnson MS, et al. The second extracellular loop of α2A-adrenoceptors contributes to the binding of yohimbine analogues. Br J Pharmacol. 2007;151:1293–1304
  20. Le Bars D, Gozariu M, Cadden SW. Animal Models of Nociception. Pharmacol Rev. 2001;53:597–652
  21. Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, et al. Cardiovascular regulation in mice lacking α2-adrenergic receptor subtypes b and c. Science. 1996;273:803–805
  22. Loomis C, Milne B, Cervenko F. A study of the interaction between clonidine and morphine on analgesia and blood pressure during continuous intrathecal infusion in the rat. Neuropharmacology. 1988;27:191–199
  23. MacMillan LB, Hein L, Smith MS, Piascik MT, Limbird LE. Central hypotensive effects of the α2A-adrenergic receptor subtype. Science. 1996;273:801–803
  24. Millan M. Evidence that an alpha-2A adrenoceptor subtype mediates antinociception in mice. Eur J Pharmacol. 1992;215:355–356
  25. Miranda H, Pinardi G. Isobolographic analysis of the antinociceptive interactions of clonidine with nonsteroidal anti-inflamatory drugs. Pharmacol Res. 2004;50:273–278
  26. Niemi R, Huuskonen J, Laine K, Jarvinen T. Synthesis, hydrolysis, and intraocular pressure lowering effects of fadolmidine prodrugs. Int J Pharm. 2005;295:121–127
  27. Onttonen T, Pertovaara A. The mechanical antihyperalgesic effect of intrathecally administered MPV-2426, a novel alpha2-adrenoceptor agonist, in a rat model of postoperative pain. Anesthesiology. 2000;92:1740–1745
  28. Ossipov M, Suarez L, Spaulding T. Antinociceptive interactions between alpha2-adrenergic and opiate agonists at the spinal level in rodents. Anesth Analg. 1989;68:194–200
  29. Ossipov MH, Lopez Y, Bian D, Nichols ML, Porreca F. Synergistic antinociceptive interactions of morphine and clonidine in rats with nerve-ligation injury. Anesthesiology. 1997;86:196–204
  30. Paris A, Mantz J, Tonner P, Hein L, Brede M, Gressens P. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the α2A-adrenoceptor subtype. Anesth Analg. 2006;102:456–461
  31. Pertovaara A. Antinociceptive properties of fadolmidine (MPV-2426), a novel alpha2-adrenoceptor agonist. CNS Drug Rev. 2004;10:117–126
  32. Philipp M, Brede M, Hein L. Physiological significance of α2-adrenergic receptor subtype diversity: One receptor is not enough. Am J Physiol Regul Integr Comp Physiol. 2002;283:R287–R295
  33. Rogawski MA, Porter RJ. Antiepileptic drugs - pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev. 1990;42:223–286
  34. Sawamura S, Kingery WS, Davies MF, Agashe GS, Clark JD, Kobilka BK, et al. Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of α2B-adrenoceptors. J Neurosci. 2000;20:9242–9251
  35. Schmidt AP, Valinetti EA, Bandeira D, Bertacchi MF, Simoes CM, Auler JO. Effects of preanesthetic administration of midazolam, clonidine, or dexmedetomidine on postoperative pain and anxiety in children. Paediatr Anaesth. 2007;17:667–674
  36. Shukry M, Kennedy K. Dexmedetomidine as a total intravenous anesthetic in infants. Paediatr Anaesth. 2007;17:581–583
  37. Sierralta F, Naquira D, Pinardi G, Miranda H. α2-adrenoceptor and opioid receptor modulation of clonidine induced antinociception. Br J Pharmacol. 1996;119:551–554
  38. Silva TG, Barbosa FSV, Brandão SSF, Lima MCA, Leite LFC, Galdino SL, et al. Synthesis and structural elucidation of new benzylidene imidazolidines and acridinylidene thiazolidines. Heterocyclic Communications. 2001;7:523–528
  39. Solomon R, Gebhart G. Synergistic antinociceptive interactions among drugs administered to the spinal cord. Anesth Analg. 1994;78:1164–1172
  40. Spaulding T, Fielding S, Venafro J, Lal H. Antinociceptive activity of clonidine and its potentiation of morphine analgesia. Eur J Pharmacol. 1979;58:19–25
  41. Stähle H. A historical perspective: Development of clonidine. Best Pract Res Clin Anaesthesiol. 2000;14:237–246
  42. Stone L, MacMillan L, Kitto K, Limbird L, Wilcox G. The alpha2 adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci. 1997;18:7157–7165
  43. Sullivan A, Kalso E, McQuay H, Dickenson A. The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in anaesthetised rat. Eur J Pharmacol. 1992;215:127–133
  44. Tallarida R. Drug synergism: Its detection and applications. J Pharmacol Exp Ther. 2001;298:865–872
  45. Tallarida R. An overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther. 2006;319:1–7
  46. Tallarida R. Interactions between drugs and occupied receptors. Pharmacol Ther. 2007;113:197–209
  47. Tallarida R, Porreca F, Cowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci. 1989;45:947–961
  48. Uhlén S, Wikberg J. Delineation of rat kidney α2A– and α2B- adrenoceptors with [3H] RX 821002 radioligand biding: computer modeling reveals that guanfacine is an α2A-selective compound. Eur J Pharmacol. 1991;202:235–243
  49. Xu M, Kontinen VK, Kalso E. Effects of radolmidine, a novel alpha2 -adrenergic agonist compared with dexmedetomidine in different pain models in the rat. Anesthesiology. 2000;93:473–481

 Supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnológico (CNPq, BR), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, BR), Fundação Universitária Jose Bonifácio (FUJB, BR), Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ, BR) and Instituto do Milênio: Inovação e Desenvolvimento de Fármacos e Medicamentos – IM-INOFAR for finantial support and fellowships.

PII: S1526-5900(09)00662-2

doi: 10.1016/j.jpain.2009.08.001

The Journal of Pain
Volume 11, Issue 1 , Pages 71-78 , January 2010

Article Tools

* Image Usage & Resolution